Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines

被引:52
作者
Chai S. [1 ]
To K.K.W. [2 ]
Lin G. [1 ]
机构
[1] School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR
[2] School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR
关键词
Doxorubicin; Curcumin; Quercetin; Ginsenosides; Panax Ginseng;
D O I
10.1186/1749-8546-5-26
中图分类号
学科分类号
摘要
Multi-drug resistance (MDR) of cancer cells severely limits therapeutic outcomes. A proposed mechanism for MDR involves the efflux of anti-cancer drugs from cancer cells, primarily mediated by ATP-binding cassette (ABC) membrane transporters including P-glycoprotein. This article reviews the recent progress of using active ingredients, extracts and formulae from Chinese medicine (CM) in circumventing ABC transporters-mediated MDR. Among the ABC transporters, Pgp is the most extensively studied for its role in MDR reversal effects. While other MDR reversal mechanisms remain unclear, Pgp inhibition is a criterion for further mechanistic study. More mechanistic studies are needed to fully establish the pharmacological effects of potential MDR reversing agents.© 2010 Chai et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 121 条
[1]  
Meszaros A., Balogh G., Multiple Drug Resistance, (2009)
[2]  
Biedler J.L., Riehm H., Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies, Cancer Res, 30, pp. 1174-1184, (1970)
[3]  
Gottesman M.M., Mechanisms of cancer drug resistance, Annu Rev Med, 53, pp. 615-617, (2002)
[4]  
La Porta C.A.M., Drug resistance in melanoma: new perspectives, Curr Med Chem, 14, 4, pp. 387-391, (2007)
[5]  
Watson J.V., Introduction to Flow Cytometry, (1991)
[6]  
Szakacs G., Paterson J.K., Ludwig J.A., Booth-Genthe C., Gottesman M.M., Targeting multidrug resistance in cancer, Nat Rev Drug Discov, 5, 3, pp. 219-234, (2006)
[7]  
Leonard G.D., Fojo T., Bates S.E., The role of ABC transporters in clinical practice, Oncologist, 8, 5, pp. 411-424, (2003)
[8]  
Juliano R.L., Ling V., A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants, Biochim Biophys Acta - Biomembranes, 455, 1, pp. 152-162, (1976)
[9]  
Cordon-Cardo C., O'Brien J.P., Boccia J., Casals D., Bertino J.R., Melamed M.R., Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues, J Histochem Cytochem, 38, 9, pp. 1277-1287, (1990)
[10]  
Thiebaut F., Tsuruo T., Hamada H., Gotteman M.M., Pastan I., Willingham M.C., Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues, Proc Natl Acad Sci USA, 84, 21, pp. 7735-7738, (1987)